BDX
Becton Dickinson and CompanyNYSEHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$42.53B
P/E Ratio
24.43
EPS
$6.12
Beta
0.35
52W High
$186.16
52W Low
$125.46
50-Day MA
$162.60
200-Day MA
$154.13
Dividend Yield
2.78%
Profit Margin
8.01%
Forward P/E
11.98
PEG Ratio
1.16
About Becton Dickinson and Company
Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
Fundamentals
| Revenue (TTM) | $21.92B |
| Gross Profit (TTM) | $10.26B |
| EBITDA | $6.04B |
| Operating Margin | 13.40% |
| Return on Equity | 6.96% |
| Return on Assets | 4.08% |
| Revenue/Share (TTM) | $76.48 |
| Book Value | $88.79 |
| Price-to-Book | 1.69 |
| Price-to-Sales (TTM) | 1.94 |
| EV/Revenue | 2.806 |
| EV/EBITDA | 12.19 |
| Quarterly Earnings Growth (YoY) | 28.60% |
| Quarterly Revenue Growth (YoY) | 1.60% |
| Shares Outstanding | $284.47M |
| Float | $283.99M |
| % Insiders | 0.40% |
| % Institutions | 96.53% |
Historical Volatility
HV 10-Day
21.55%
HV 20-Day
17.98%
HV 30-Day
19.22%
HV 60-Day
25.00%
HV Rank
18.3%
Volatility is currently expanding
Analyst Ratings
Consensus ($191.46 target)
1
Strong Buy4
Buy9
HoldData last updated: 4/29/2026